Anthera Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced the appointment of Northern Illinois University alumnus Brian R. Mueller to its board of directors and as chairman of the Audit Committee of the Board of Directors. Mueller currently serves as group vice president, corporate controller and chief accounting officer of BioMarin Pharmaceutical Inc., a publicly-traded biopharmaceutical company.
“We are pleased to welcome Mr. Mueller to our board of directors. Brian’s global experience in financial operations and extensive experience with strategic transactions will most certainly add value to Anthera as we continue to advance our late-stage clinical trials,” said Dr. Chris Henney, chairman of Anthera Pharmaceuticals.
Mueller, who earned his bachelor’s degree in Accountancy from NIU, has been with BioMarin since 2002 after a combination of seven years in public accounting in Arthur Andersen, LLP and KPMG, LLP.
“We look forward to leveraging Brian’s accomplishments at BioMarin and his leadership in guiding us through our next stage of growth,” Henney added.